 EffecT is a prospective, randomized multicenter study to assess whether management of atrial fibrillation AF as well as the early optimization of cardiac resynchronization therapy CRT via Home Monitoring decreases mortality and morbidity compared to conventional treatment in subjects with a standard indication for CRT with Implantable Cardioverter Defibrillator ICD backup and AF. 